BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 14692614)

  • 1. Toxicogenomics in drug development.
    Guerreiro N; Staedtler F; Grenet O; Kehren J; Chibout SD
    Toxicol Pathol; 2003; 31(5):471-9. PubMed ID: 14692614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of toxicogenomics to toxicology: basic concepts in the analysis of microarray data.
    Irwin RD; Boorman GA; Cunningham ML; Heinloth AN; Malarkey DE; Paules RS
    Toxicol Pathol; 2004; 32 Suppl 1():72-83. PubMed ID: 15209406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicogenomics in predictive toxicology in drug development.
    Suter L; Babiss LE; Wheeldon EB
    Chem Biol; 2004 Feb; 11(2):161-71. PubMed ID: 15123278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity.
    Merrick BA; Bruno ME
    Curr Opin Mol Ther; 2004 Dec; 6(6):600-7. PubMed ID: 15663324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine.
    Youns M; Hoheisel JD; Efferth T
    Planta Med; 2010 Dec; 76(17):2019-25. PubMed ID: 20957595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Toxicogenomics as a tool for evaluation of chemical effects].
    Watanabe H
    Yakugaku Zasshi; 2007 Dec; 127(12):1967-74. PubMed ID: 18057786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology.
    Heijne WH; Kienhuis AS; van Ommen B; Stierum RH; Groten JP
    Expert Rev Proteomics; 2005 Oct; 2(5):767-80. PubMed ID: 16209655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The promise of toxicogenomics.
    Waring JF; Halbert DN
    Curr Opin Mol Ther; 2002 Jun; 4(3):229-35. PubMed ID: 12139308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix database.
    Ganter B; Snyder RD; Halbert DN; Lee MD
    Pharmacogenomics; 2006 Oct; 7(7):1025-44. PubMed ID: 17054413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?
    Lühe A; Suter L; Ruepp S; Singer T; Weiser T; Albertini S
    Mutat Res; 2005 Aug; 575(1-2):102-15. PubMed ID: 15924886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of toxicogenomics in drug development.
    Gant TW
    Drug News Perspect; 2003 May; 16(4):217-21. PubMed ID: 12942151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in "omics" technologies for toxicological research].
    Inadera H; Uchida M; Shimomura A
    Nihon Eiseigaku Zasshi; 2007 Jan; 62(1):18-31. PubMed ID: 17334089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of toxicogenomic data in risk assessment: a regulatory perspective.
    Chan VS; Theilade MD
    Clin Toxicol (Phila); 2005; 43(2):121-6. PubMed ID: 15822767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toxicogenomics--a new paradigm of toxicology and birth of reverse toxicology].
    Hirabayashi Y; Inoue T
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2002; (120):39-52. PubMed ID: 12638183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA microarray technology in toxicogenomics of aquatic models: methods and applications.
    Ju Z; Wells MC; Walter RB
    Comp Biochem Physiol C Toxicol Pharmacol; 2007 Feb; 145(1):5-14. PubMed ID: 16828578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicogenomics in biomarker discovery.
    Decristofaro MF; Daniels KK
    Methods Mol Biol; 2008; 460():185-94. PubMed ID: 18449488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives on the Use of Toxicogenomics to Assess Environmental Risk.
    Portugal J; Mansilla S; Piña B
    Front Biosci (Landmark Ed); 2022 Oct; 27(10):294. PubMed ID: 36336867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicogenomics: a pivotal piece in the puzzle of toxicological research.
    Gatzidou ET; Zira AN; Theocharis SE
    J Appl Toxicol; 2007; 27(4):302-9. PubMed ID: 17429800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery in toxicology: mediation by gene expression array technology.
    Hamadeh HK; Bushel P; Paules R; Afshari CA
    J Biochem Mol Toxicol; 2001; 15(5):231-42. PubMed ID: 11835620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicogenomics using yeast DNA microarrays.
    Yasokawa D; Iwahashi H
    J Biosci Bioeng; 2010 Nov; 110(5):511-22. PubMed ID: 20624688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.